Lab Information

Dr. Peter Lakatos

Centre for Innovative Medicine
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 50%
 Epidemiology: 0%
 Evaluation: 50%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Inflammatory bowel diseases (IBD) • gastroenterology • colitis • Crohn’s disease

Team Members

Name Position

Latest Publications

  1. Wetwittayakhlang, P. & Lakatos, P. L. (2021). Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!. Journal of Crohn's & colitis.
  2. Khoury, A. A., Balram, B., Bessissow, T., Afif, W., Gonczi, L., Abreu, M. & Lakatos, P. L. (2021). Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive diseases and sciences.
  3. Santella, C., Bitton, A., Filliter, C., Bessissow, T., Vutcovici, M., Lakatos, P. L. & Brassard, P. (2021). Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases.
  4. Al Khoury, A., Xiao, Y., Golovics, P. A., Kohen, R., Afif, W., Wild, G., Friedman, G., Galiatsatos, P., Hilzenrat, N., Szilagyi, A., Wyse, J., Cohen, A., Bitton, A., Bessissow, T. & Lakatos, P. L. (2021). Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
  5. Zhao, M., Gönczi, L., Lakatos, P. L. & Burisch, J. (2021). The burden of inflammatory bowel disease in Europe in 2020. Journal of Crohn's & colitis.
  6. Restellini, S. & Lakatos, P. L. (2021). Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle. Journal of Crohn's & colitis.
  7. Al Khoury, A., Singh, K., Kurti, Z., Gonczi, L., Golovics, P., Kohen, R., Afif, W., Wild, G., Bitton, A., Bessissow, T. & Lakatos, P. L. (2020). The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center. Journal of gastrointestinal and liver diseases : JGLD, vol. 29, p. 555-559.
  8. Radeke, H. H., Stein, J., Van Assche, G., Rogler, G., Lakatos, P. L., Muellershausen, F., Moulin, P., Jarvis, P., Colin, L., Gergely, P. & Kruis, W. (2020). A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis. Inflammatory intestinal diseases, vol. 5, p. 180-190.
  9. Hirten, R. P., Lakatos, P. L., Halfvarson, J. & Colombel, J. F. (2021). Reply. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol. 19, p. 1301-1302.
  10. Xiao, Y., Lakatos, P. L. & Bessissow, T. (2020). Adenocarcinoma Within Carpet-Like Pseudopolyposis. ACG case reports journal, vol. 7, p. e00415.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile


Latest News


Research groups